Proleukin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Clinigen Group Plc. The primary component is Aldesleukin.
Product ID | 76310-022_3b04162e-e9f0-4fea-9dc0-62a9ebd6ef9e |
NDC | 76310-022 |
Product Type | Human Prescription Drug |
Proprietary Name | Proleukin |
Generic Name | Aldesleukin |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1992-05-05 |
Marketing Category | BLA / BLA |
Application Number | BLA103293 |
Labeler Name | Clinigen Group PLC |
Substance Name | ALDESLEUKIN |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Increased Lymphocyte Activation [PE],Increased Lymphocyte Cell Production [PE],Interleukin-2 [CS],Lymphocyte Growth Factor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-12-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103293 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-12-31 |
Ingredient | Strength |
---|---|
ALDESLEUKIN | 1.1 mg/mL |
SPL SET ID: | deead498-9f19-48cf-87c7-6caf2263f2ab |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
65483-116 | Proleukin | aldesleukin |
76310-022 | Proleukin | aldesleukin |
17089-380 | GUNA-IL 2 | ALDESLEUKIN |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PROLEUKIN 86330987 4761828 Live/Registered |
CLINIGEN HOLDINGS LIMITED 2014-07-08 |
PROLEUKIN 85199293 not registered Dead/Abandoned |
Novartis Vaccines & Diagnostics, Inc. 2010-12-16 |
PROLEUKIN 79062942 3639936 Dead/Cancelled |
Novartis AG 2008-08-07 |
PROLEUKIN 76532544 2857698 Dead/Cancelled |
Chiron Corporation 2003-07-25 |
PROLEUKIN 73523710 1369770 Live/Registered |
CETUS CORPORATION 1985-02-25 |